Biblio
Journal Article
Qin Y, Han S, Yu Y, Qi D, Ran M, Yang M, Liu Y, Li Y, Lu L, Liu Y, et al. Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy. Liver Int. 2024.
Wong SHong Dexte, Xu X, Chen X, Xin Y, Xu L, Lai CHim Nathan, Oh J, Wong WKi Ricky, Wang X, Han S, et al. Manipulation of the Nanoscale Presentation of Integrin Ligand Produces Cancer Cells with Enhanced Stemness and Robust Tumorigenicity. Nano Lett. 2021.